Esophageal Diseases  >>  timapiprant (OC000459)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
timapiprant (OC000459) / Chiesi
NCT01056783: Proof of Concept Study of OC000459 in Eosinophilic Esophagitis

Completed
2
26
Europe
OC000459, Placebo
Oxagen Ltd
Eosinophilic Esophagitis
06/11
06/11

Download Options